News from kindred biosciences, inc

Jun 11, 2014, 09:01 ET

Kindred Bio to Host Investor Breakfast on June 13 in New York City

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

May 21, 2014, 16:01 ET

Kindred Bio to Present at Craig-Hallum, Stifel, and Jefferies Conferences

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...

May 12, 2014, 16:01 ET

Kindred Biosciences Announces First Quarter 2014 Financial Results and Completion of Enrollment in CereKin Pivotal Study

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the quarter ended March 31, 2014. In addition, Kindred Bio...

May 06, 2014, 09:03 ET

Kindred Bio to Announce First Quarter 2014 Financial Results on Monday, May 12th

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today that it...

Apr 08, 2014, 16:01 ET

Kindred Bio Announces Closing of Public Offering and Exercise of Over-Allotment Option

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the closing...

Apr 04, 2014, 09:03 ET

Kindred Bio to Present at Needham 13th Annual Healthcare Conference

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Apr 03, 2014, 09:03 ET

Kindred Bio Announces Pricing of Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing...

Mar 31, 2014, 16:09 ET

Kindred Bio Announces Launch of Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the...

Mar 31, 2014, 09:03 ET

Kindred Bio and X-Body Announce an Exclusive Collaboration for Discovery of Antibodies for Companion Animal Health

 Kindred Biosciences, Inc. (NASDAQ: KIN) and X-Body Biosciences (X-Body) jointly announced today an exclusive alliance in which X-Body will...

Mar 28, 2014, 09:03 ET

Kindred Bio Announces Initiation of Pivotal Clinical Study for SentiKin™ in Dogs

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Mar 24, 2014, 09:10 ET

Kindred Bio Appoints Dr. Blake Hawley as Chief Commercial Officer, Announces Upcoming Inclusion in Russell 2000

Kindred Biosciences, Inc. (NASDAQ: KIN) announced today that it has appointed Blake Hawley, D.V.M., as its Chief Commercial Officer. Separately, it...

Mar 18, 2014, 17:09 ET

Kindred Bio Announces Proposed Public Offering

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has...

Mar 06, 2014, 08:00 ET

Kindred Biosciences Announces Fourth Quarter and Year End 2013 Financial Results

 Kindred Biosciences, Inc. (NASDAQ: KIN) today announced financial results for the fourth quarter and year ended December 31, 2013. Kindred...

Mar 04, 2014, 10:24 ET

Kindred Bio to Present at Roth Capital Partners 26th Annual Growth Stock Conference

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it...

Feb 27, 2014, 09:10 ET

Kindred Bio to Announce Fourth Quarter and Year-End Financial Results on Thursday, March 6th

 Kindred Biosciences, Inc. (NASDAQ:  KIN), a biopharmaceutical company focused on saving and improving the lives of pets, announced today...

Feb 20, 2014, 09:10 ET

Kindred Bio Announces Initiation of Pivotal Clinical Study for AtoKin™ in Dogs

 Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Feb 06, 2014, 21:01 ET

Kindred Bio to Present at 2014 Leerink Global Healthcare Conference

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that...

Jan 14, 2014, 08:49 ET

New Year's Resolution: Give Pets the Gift of Top-Notch Health Care

As pet owners drew up their lists of New Year's resolutions for 2014, there's no doubt many of them wrote: "Take better care of my furry...

Aug 22, 2013, 21:01 ET

Dr. Stephen Sundlof, Former Director of FDA's CVM, Joins Kindred Bio

Kindred Biosciences, Inc. (Kindred Bio) announced today that it has appointed Stephen Sundlof, DVM, PhD, former Director of Center for Veterinary...

Aug 07, 2013, 09:01 ET

Kindred Bio Announces Initiation of Pivotal Clinical Study for CereKin™

Kindred Biosciences, Inc. (Kindred Bio) announced today that it has initiated a pivotal clinical trial for CereKin™ (KIND-001) in dogs with...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer